Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1717-1725

  Ding, Hanlu ^a   Wang, Li ^a   Wu, Xiongfei ^b   Yan, Jun ^c   He, Yani ^c   Ni, Bing ^b   Gao, Wenda ^d   Zhong, Xuemei ^e  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BAFF; BXSB mice; Lupus, autoimmunity; Receptor antagonist

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; MUTANT PROTEIN;

ANIMAL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD; CELL PROLIFERATION; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MALE; METABOLISM; MOUSE; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL PROLIFERATION; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE COUNT; MALE; MICE; MUTANT PROTEINS; RECOMBINANT FUSION PROTEINS;

ANIMALIA; MURINAE; MUS;

EID: 77955140720     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00817.x     Document Type: Article

References (39)

1. Klinman DM, Shirai A, Ishigatsubo Y. Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus. Arthritis Rheum. 1991, 34:1404-10.
2. Mitchison NA, Wedderburn LR. B cells in autoimmunity. Proc Natl Acad Sci USA. 2000, 97:8750-1.
3. Chan OT, Hannum LG, Haberman AM. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med. 1999, 189:1639-48.
4. Moore PA, Belvedere O, Orr A. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999, 285:260-3.
5. Mackay F, Schneider P, Rennert P. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003, 21:231-64.
6. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002, 2:465-75.
7. Mackay F, Silveira PA, Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007, 19:327-36.
8. Mackay F, Woodcock SA, Lawton P. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999, 190:1697-710.
9. Gross JA, Johnston J, Mudri S. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000, 404:995-9.
10. Khare SD, Sarosi I, Xia XZ. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA. 2000, 97:3370-5.
11. Groom JR, Fletcher CA, Walters SN. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007, 204:1959-71.
12. Zhang J, Roschke V, Baker KP. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol. 2001, 166:6-10.
13. Cheema GS, Roschke V, Hilbert DM. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001, 44:1313-9.
14. Stohl W, Metyas S, Tan SM. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003, 48:3475-86.
15. Becker-Merok A, Nikolaisen C, Nossent HC. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus. 2006, 15:570-6.
16. Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol. 2006, 18:263-75.
17. Thompson JS, Bixler SA, Qian F. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001, 293:2108-11.
18. Liu W, Szalai A, Zhao L. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Arthritis Rheum. 2004, 50:1884-96.
19. Ramanujam M, Wang X, Huang W. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest. 2006, 116:724-34.
20. Bossen C, Ingold K, Tardivel A. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem. 2006, 281:13964-71.
21. Taylor L, Bachler M, Duncan I. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions. J Leukoc Biol. 2002, 72:522-9.
22. Pelletier M, Thompson JS, Qian F. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem. 2003, 278:33127-33.
23. Gao W, Demirci G, Strom TB. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation. 2003, 76:994-9.
24. Ravirajan CT, Sarraf CE, Anilkumar TV. An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE). Clin Exp Immunol. 1996, 105:306-12.
25. Knight JG, Adams DD, Purves HD. The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid. Clin Exp Immunol. 1977, 28:352-8.
26. Kinoshita K, Tesch G, Schwarting A. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol. 2000, 164:6046-56.
27. Watson ML, Rao JK, Gilkeson GS. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992, 176:1645-56.
28. Zheng SG, Wang JH, Koss MN. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol. 2004, 172:1531-9.
29. Ye Q, Wang L, Wells AD. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol. 2004, 34:2750-9.
30. Gorelik L, Cutler AH, Thill G. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol. 2004, 172:762-6.
31. Avery DT, Kalled SL, Ellyard JI. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest. 2003, 112:286-97.
32. Ng LG, Sutherland AP, Newton R. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004, 173:807-17.
33. Andrews BS, Eisenberg RA, Theofilopoulos AN. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978, 148:1198-215.
34. Izui S, Ibnou-Zekri N, Fossati-Jimack L. Lessons from BXSB and related mouse models. Int Rev Immunol. 2000, 19:447-72.
35. Shlomchik MJ, Madaio MP, Ni D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med. 1994, 180:1295-306.
36. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol. 1989, 7:625-55.
37. Wong M, Ziring D, Korin Y. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008, 126:121-36.
38. Woof JM, Partridge LJ, Jefferis R. Localisation of the monocyte-binding region on human immunoglobulin G. Mol Immunol. 1986, 23:319-30.
39. Lewis EC, Shapiro L, Bowers OJ. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA. 2005, 102:12153-8.